Agereh Cancels Previously Announced Non-Brokered Private Placement and Announces Proposed New Private Placement and Issuance of Stock Options
Agereh (OTCQB:CRBAF) cancelled its previously announced non‑brokered placement and announced a proposed new non‑brokered private placement to raise up to $500,000 by issuing up to 7,407,407 Units at $0.0675 per Unit. Each Unit includes one share and one warrant exercisable at $0.09 for 24 months. Units will be offered under the LIFE exemption in Canada (except Québec) and will not be subject to resale restrictions. The New Offering requires necessary approvals, including conditional TSXV approval; an offering document will be filed on Sedarplus and the company website. The company also granted 400,000 stock options at $0.12 (200,000 vest immediately; 200,000 vest Jan 1, 2026), subject to TSXV approval.
Agereh (OTCQB:CRBAF) ha cancellato il precedente collocamento non brokerato annunciato e ha annunciato una nuova offerta privata non brokerata da proporre di raccogliere fino a 500.000 dollari emettendo fino a 7.407.407 unità a 0,0675 dollari per unità. Ogni unità comprende una azione e un warrant eseguibile a 0,09 dollari per 24 mesi. Le unità saranno offerte secondo l’eccezione LIFE in Canada (eccetto il Québec) e non saranno soggette a restrizioni di rivendita. La nuova offerta richiede le necessarie approvazioni, inclusa un’approvazione condizionale della TSXV; un documento di offerta sarà depositato su Sedarplus e sul sito web della società. L’azienda ha anche concesso 400.000 opzioni azionarie a 0,12 dollari (200.000 maturano immediatamente; 200.000 matureranno il 1 gennaio 2026), soggette all’approvazione della TSXV.
Agereh (OTCQB:CRBAF) canceló su colocación no brokerada previamente anunciada y anunció una nueva oferta privada no brokerada para recaudar hasta $500,000 emitiendo hasta 7,407,407 Unidades a $0,0675 por Unidad. Cada Unidad incluye una acción y un warrant exercitable a $0,09 por 24 meses. Las Unidades serán ofrecidas bajo la exención LIFE en Canadá (salvo Quebec) y no estarán sujetas a restricciones de reventa. La Nueva Oferta requiere las aprobaciones necesarias, incluida una aprobación condicional de TSXV; un documento de la oferta se presentará en Sedarplus y en el sitio web de la empresa. La empresa también otorgó 400,000 opciones sobre acciones a $0,12 (200,000 vencen de inmediato; 200,000 vencen el 1 de enero de 2026), sujeto a la aprobación de TSXV.
Agereh (OTCQB:CRBAF)는 이전에 발표된 비 브로커드 배치를 취소하고 새로운 비 브로커드 비공개 배치를 제안하여 최대 500,000달러를 모으고자 하며, 단위당 0.0675달러에 7,407,407 유닛까지 발행합니다. 각 유닛에는 하나의 주식과 24개월 동안 행사 가능한 워런트가 포함됩니다. 유닛은 캐나다에서 LIFE 면제에 따라 제공되며(퀘벡 제외), 재매도 제한이 없습니다. 새 제안은 필요한 승인을 요구하며, TSXV의 조건부 승인을 포함합니다; 제안 문서는 Sedarplus와 회사 웹사이트에 게재될 예정입니다. 또한 회사는 0.12달러에 40만 주의 주식 옵션을 부여했으며(200,000주는 즉시 행사 가능; 200,000주는 2026년 1월 1일에 행사 가능), 이는 TSXV의 승인을 조건으로 합니다.
Agereh (OTCQB:CRBAF) a annulé son placement non‑intermédié précédemment annoncé et a annoncé une nouvelle offre privée non brokerée proposée pour lever jusqu'à 500 000 dollars en émettant jusqu'à 7 407 407 unités à 0,0675 dollars par unité. Chaque unité comprend une action et un warrant exerçable à 0,09 dollar pour 24 mois. Les unités seront offertes sous l
exemption LIFE au Canada (à l'exception du Québec) et ne seront pas soumises à des restrictions de revente. La nouvelle offre nécessite les approbations nécessaires, y compris l'approbation conditionnelle de la TSXV; un document d'offre sera déposé sur Sedarplus et sur le site Web de l'entreprise. La société a également accordé 400 000 options d'achat d'actions à 0,12 dollar (200 000 se délivrent immédiatement; 200 000 se délivreront le 1er janvier 2026), sous réserve de l'approbation de la TSXV.
Agereh (OTCQB:CRBAF) hat seine zuvor angekündigte nicht‑ brokerisierte Platzierung storniert und eine vorgeschlagene neue nicht brokerisierte Privatplatzierung angekündigt, um bis zu 500.000 USD zu beschaffen, indem bis zu 7.407.407 Units zu einem Preis von 0,0675 USD pro Unit ausgegeben werden. Jede Unit umfasst eine Aktie und eine Warrant, der zu 0,09 USD für 24 Monate ausgeübt werden kann. Die Units werden unter der LIFE-Ausnahme in Kanada (außer Québec) angeboten und unterliegen keinen Wiederverkaufsbeschränkungen. Das neue Angebot erfordert die notwendigen Genehmigungen, einschließlich einer bedingten TSXV-Genehmigung; ein Angebotsdokument wird auf Sedarplus und auf der Website des Unternehmens eingereicht. Das Unternehmen hat außerdem 400.000 Aktienoptionen zu 0,12 USD gewährt (200.000 verfallen sofort; 200.000 verfallen am 1. Januar 2026), vorbehaltlich der Genehmigung durch die TSXV.
Agereh (OTCQB:CRBAF) ألغت طرحها غير الوسيط الذي أعلنت عنه سابقاً وأعلنت عن طرح خاص غير وسيط جديد مقترح لجمع حتى 500,000 دولار من خلال إصدار حتى 7,407,407 وحدة بسعر 0.0675 دولار للوحدة. تتضمن كل وحدة سهما واحدا و WARRANT قابلة للممارسة بسعر 0.09 دولار لمدة 24 شهراً. ستعرض الوحدات وفق استثناء LIFE في كندا (باستثناء كيبيك) ولن تخضع لقيود إعادة البيع. يتطلب العرض الجديد الموافقات اللازمة، بما في ذلك الموافقة الشرطية من TSXV؛ سيتم تقديم وثيقة العرض على Sedarplus وعلى موقع الشركة. كما منحت الشركة 400,000 خيار أسهم بسعر 0.12 دولار (200,000 تستحق فوراً؛ 200,000 تستحق في 1 يناير 2026)، رهناً بموافقة TSXV.
- Up to $500,000 gross proceeds via the New Offering
- Offering uses the LIFE exemption to access Canadian investors
- Units and underlying securities not subject to resale restrictions
- 200,000 stock options vested immediately
- Issuance of up to 7,407,407 Unit Shares may dilute existing holders
- Each Unit warrant exercisable for 7,407,407 additional shares at $0.09
- 400,000 stock options granted at $0.12 add potential dilution
- New Offering subject to TSXV conditional approval; not guaranteed
EDMONTON, AB / ACCESS Newswire / November 5, 2025 / Agereh Technologies Inc. ("Agereh" or the "Company") (TSXV:AUTO)(OTCQB:CRBAF) announces that it will not be proceeding with the non-brokered private placement of units previously announced on August 27 and October 14, 2025.
The Company now intends to complete a non-brokered private placement for aggregate gross proceeds of up to
The Units to be issued under the New Offering will be offered to purchasers pursuant to the listed issuer financing exemption (LIFE) under Part 5A of National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), in all the provinces of Canada, except Québec. The Units, including the Unit Shares and Unit Warrants underlying the Unit, will not be subject to resale restrictions pursuant to applicable Canadian securities laws.
The New Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the conditional approval of the TSX Venture Exchange (the "TSXV").
An offering document relating to the New Offering will be filed and accessible under the Company's profile at www.sedarplus.ca and on the Company's website at www.agereh.com. Prospective investors should read this offering document before making an investment decision.
Issuance of Stock Options
The Company also announces that it has granted an aggregate of 400,000 stock options (the "Options") to directors the Company to purchase common shares of the Company at a price of
About Agereh Technologies Inc.
Agereh is a Canadian-based AI technology company whose platforms target advanced technology solutions for the transportation industry. The first application developed is harnessing the power of Artificial Intelligence to accurately predict the best financing scenario for consumers, all while keeping the consumer anonymous. Upcoming products will continue to deliver advanced technology solutions that address critical challenges in the transportation industry.
ON BEHALF OF THE BOARD OF DIRECTORS OF AGEREH TECHNOLOGIES INC.
Ken Brizel, CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Ken Brizel
CEO
info@agereh.com
Website: www.agereh.com
Notice Regarding Forward-Looking Information:
This news release contains forward-looking statements including but not limited to statements regarding the Company's business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.
SOURCE: Agereh Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What is Agereh proposing to raise in the November 5, 2025 private placement (CRBAF)?
What does each Unit in Agereh's (CRBAF) new placement include and what are the warrant terms?
Are the Units from Agereh's (CRBAF) New Offering subject to Canadian resale restrictions?
What approvals does Agereh (CRBAF) need before completing the New Offering?
How many stock options did Agereh (CRBAF) grant and what are the vesting terms?
Where can investors find the offering document for Agereh's (CRBAF) New Offering?
